A meta-analysis of the use of probiotics to alleviate depressive symptoms

Journal of Affective Disorders

Volumn 228, Issue , 2018, Pages 13-19

  Ng, Qin Xiang ^a   Peters, Christina ^b   Ho, Collin Yih Xian ^c   Lim, Donovan Yutong ^d   Yeo, Wee Song ^c,e  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d INSTITUTE OF MENTAL HEALTH   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Depression; Gut brain axis; Lactobacillus; MDD; Mood; Probiotics

Indexed keywords

PLACEBO; PROBIOTIC AGENT; YOGHURT;

ALTERNATIVE MEDICINE; BECK DEPRESSION INVENTORY; BIBLIOGRAPHIC DATABASE; BIFIDOBACTERIUM; DEPRESSION; DIET SUPPLEMENTATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MENTAL PATIENT; META ANALYSIS; MICROBIOME; NONHUMAN; PATIENT PARTICIPATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT RESPONSE; AFFECT;

AFFECT; BIFIDOBACTERIUM; DEPRESSION; GASTROINTESTINAL MICROBIOME; HUMANS; LACTOBACILLUS; PROBIOTICS;

EID: 85036528107     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.11.063     Document Type: Review

References (45)

1. Ait-Belgnaoui, A., Colom, A., Braniste, V., Ramalho, L., Marrot, A., Cartier, C., Tompkins, T., Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol. Motil. 26:4 (2014), 510–520, 10.1111/nmo.12295.
2. Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Esmaillzadeh, A., Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition 32:3 (2016), 315–320, 10.1016/j.nut.2015.09.003.
3. Barrett, E., Ross, R.P., O'Toole, P.W., Fitzgerald, G.F., Stanton, C., gamma-Aminobutyric acid production by culturable bacteria from the human intestine. J. Appl. Microbiol. 113:2 (2012), 411–417, 10.1111/j.1365-2672.2012.05344.x.
4. Benton, D., Williams, C., Brown, A., Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur. J. Clin. Nutr. 61:3 (2007), 355–361, 10.1038/sj.ejcn.1602546.
5. Bercik, P., Park, A.J., Sinclair, D., Khoshdel, A., Lu, J., Huang, X., Verdu, E.F., The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut–brain communication. Neurogastroenterol. Motil. 23:12 (2011), 1132–1139, 10.1111/j.1365-2982.2011.01796.x.
6. Bezkorovainy, A., Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr. 73:2 Suppl (2001), 399s–405s.
7. Blier, P., Keller, M.B., Pollack, M.H., Thase, M.E., Zajecka, J.M., Dunner, D.L., Preventing recurrent depression: long-term treatment for major depressive disorder. J. Clin. Psychiatry, 68(3), 2007, e06.
8. Bolla, P.A., Serradell Mde, L., de Urraza, P.J., De Antoni, G.L., Effect of freeze-drying on viability and in vitro probiotic properties of a mixture of lactic acid bacteria and yeasts isolated from kefir. J. Dairy Res. 78:1 (2011), 15–22, 10.1017/s0022029910000610.
9. Carabotti, M., Scirocco, A., Maselli, M.A., Severi, C., The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. 28 (2015), 203–209.
10. Chung, Y.C., Jin, H.M., Cui, Y., Kim, D.S., Jung, J.M., Park, J., Chae, S.W., Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. J. Funct. Foods 10 (2014), 465–474, 10.1016/j.jff.2014.07.007.
11. Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., Dinan, T.G., The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J. Psychiatr. Res 43:2 (2008), 164–174, 10.1016/j.jpsychires.2008.03.009.
12. Dhakal, R., Bajpai, V.K., Baek, K.H., Production of gaba (gamma - Aminobutyric acid) by microorganisms: a review. Braz. J. Microbiol. 43:4 (2012), 1230–1241, 10.1590/s1517-83822012000400001.
13. Ferguson, J.M., SSRI antidepressant medications: adverse effects and tolerability. Prim. Care Companion J. Clin. Psychiatry 3:1 (2001), 22–27.
14. Goehler, L.E., Park, S.M., Opitz, N., Lyte, M., Gaykema, R.P., Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav. Immun. 22:3 (2008), 354–366, 10.1016/j.bbi.2007.08.009.
15. Govender, M., Choonara, Y.E., Kumar, P., du Toit, L.C., van Vuuren, S., Pillay, V., A review of the advancements in probiotic delivery: conventional vs. non-conventional formulations for intestinal flora supplementation. AAPS PharmSciTech 15:1 (2014), 29–43, 10.1208/s12249-013-0027-1.
16. Higgins, J.P., Altman, D.G., Gotzsche, P.C., Juni, P., Moher, D., Oxman, A.D., Sterne, J.A., The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011, d5928, 10.1136/bmj.d5928.
17. Huang, R., Wang, K., Hu, J., Effect of probiotics on depression: a systematic review and meta-analysis of randomized controlled trials. Nutrients, 8(8), 2016, 483, 10.3390/nu8080483.
18. Isolauri, E., Sutas, Y., Kankaanpaa, P., Arvilommi, H., Salminen, S., Probiotics: effects on immunity. Am. J. Clin. Nutr. 73:2 Suppl (2001), 444s–450s.
19. Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J., Gavaghan, D.J., McQuay, H.J., Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin. Trials 17:1 (1996), 1–12.
20. Jakobsen, J.C., Katakam, K.K., Schou, A., Hellmuth, S.G., Stallknecht, S.E., Leth-Moller, K., Gluud, C., Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry, 17(1), 2017, 58, 10.1186/s12888-016-1173-2.
21. Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Ruan, B., Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav. Immun. 48 (2015), 186–194, 10.1016/j.bbi.2015.03.016.
22. Keene, M.S., Eaddy, M.T., Nelson, W.W., Sarnes, M.W., Adherence to paroxetine CR compared with paroxetine IR in a Medicare-eligible population with anxiety disorders. Am. J. Manag Care 11:12 Suppl (2005), S362–S369.
23. Kelly, J.R., Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Hyland, N.P., Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front. Cell Neurosci., 2015, 9, 10.3389/fncel.2015.00392.
24. Khin, N.A., Chen, Y.F., Yang, Y., Yang, P., Laughren, T.P., Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications. J. Clin. Psychiatry 72:4 (2011), 464–472, 10.4088/JCP.10m06191.
25. Kirsch, I., Deacon, B.J., Huedo-Medina, T.B., Scoboria, A., Moore, T.J., Johnson, B.T., Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med., 5(2), 2008, e45, 10.1371/journal.pmed.0050045.
26. Leonard, B.E., The concept of depression as a dysfunction of the immune system. Curr. Immunol. Rev. 6:3 (2010), 205–212, 10.2174/157339510791823835.
27. Lyte, M., Li, W., Opitz, N., Gaykema, R.P., Goehler, L.E., Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol. Behav. 89:3 (2006), 350–357, 10.1016/j.physbeh.2006.06.019.
28. Mayer, E.A., Knight, R., Mazmanian, S.K., Cryan, J.F., Tillisch, K., Gut microbes and the brain: paradigm shift in neuroscience. J. Neurosci. 34:46 (2014), 15490–15496, 10.1523/jneurosci.3299-14.2014.
29. Messaoudi, M., Violle, N., Bisson, J.F., Desor, D., Javelot, H., Rougeot, C., Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2:4 (2011), 256–261, 10.4161/gmic.2.4.16108.
30. Mohammadi, A.A., Jazayeri, S., Khosravi-Darani, K., Solati, Z., Mohammadpour, N., Asemi, Z., Eghtesadi, S., The effects of probiotics on mental health and hypothalamic-pituitary-adrenal axis: a randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutr. Neurosci. 19:9 (2016), 387–395, 10.1179/1476830515y.0000000023.
31. Nishihara, J., Kagami-Katsuyama, H., Tanaka, A., Nishimura, M., Kobayashi, T., Kawasaki, Y., Elevation of natural killer cell activity and alleviation of mental stress by the consumption of yogurt containing Lactobacillus gasseri SBT2055 and Bifidobacterium longum SBT2928 in a double-blind, placebo-controlled clinical trial. J. Funct. Foods 2014:11 (2014), 261–268, 10.1016/j.jff.2014.09.002.
32. World Health Organization, 2017. Depression and Other Common Mental Disorders: Global Health Estimates.
33. Östlund-Lagerström, L., Kihlgren, A., Repsilber, D., Bjorksten, B., Brummer, R.J., Schoultz, I., Probiotic administration among free-living older adults: a double blinded, randomized, placebo-controlled clinical trial. Nutr. J., 15(1), 2016, 80, 10.1186/s12937-016-0198-1.
34. Perez-Cornago, A., Sanchez-Villegas, A., Bes-Rastrollo, M., Gea, A., Molero, P., Lahortiga-Ramos, F., Martinez-Gonzalez, M.A., Intake of high-fat yogurt, but not of low-fat yogurt or prebiotics, is related to lower risk of depression in women of the SUN cohort study. J. Nutr. 146:9 (2016), 1731–1739, 10.3945/jn.116.233858.
35. Pinto-Sanchez, M.I., Hall, G.B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J.T., Bercik, P., Probiotic bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology, 2017, 10.1053/j.gastro.2017.05.003.
36. Rao, A.V., Bested, A.C., Beaulne, T.M., Katzman, M.A., Iorio, C., Berardi, J.M., Logan, A.C., A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog., 1(1), 2009, 6, 10.1186/1757-4749-1-6.
37. Romijn, A.R., Rucklidge, J.J., Kuijer, R.G., Frampton, C., A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression. Aust. N. Z. J. Psychiatry, 2017, 10.1177/0004867416686694 (4867416686694).
38. Roueche, E., Serris, E., Thomas, G., Périer-Cambry, L., Influence of temperature on the compaction of an organic powder and the mechanical strength of tablets. Powder Technol. 162:2 (2006), 138–144, 10.1016/j.powtec.2005.12.005.
39. Savignac, H.M., Kiely, B., Dinan, T.G., Cryan, J.F., Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol. Motil. 26:11 (2014), 1615–1627, 10.1111/nmo.12427.
40. Schmidt, C., Mental health: thinking from the gut. Nature 518:7540 (2015), S12–S15, 10.1038/518S13a.
41. Shinkai, S., Toba, M., Saito, T., Sato, I., Tsubouchi, M., Taira, K., Kohno, S., Immunoprotective effects of oral intake of heat-killed Lactobacillus pentosus strain b240 in elderly adults: a randomised, double-blind, placebo-controlled trial. Br. J. Nutr. 109:10 (2013), 1856–1865, 10.1017/s0007114512003753.
42. Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J.A., Colzato, L.S., A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav. Immun. 48 (2015), 258–264, 10.1016/j.bbi.2015.04.003.
43. Tannock, G.W., Savage, D.C., Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract. Infect. Immun. 9:3 (1974), 591–598.
44. Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., Hsiao, E.Y., Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:2 (2015), 264–276, 10.1016/j.cell.2015.02.047.
45. Zuccotti, G.V., Meneghin, F., Raimondi, C., Dilillo, D., Agostoni, C., Riva, E., Giovannini, M., Probiotics in clinical practice: an overview. J. Int. Med. Res. 36:Suppl 1 (2008), 1a–53a, 10.1177/14732300080360s101.